GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Mon, 22 Apr 2024

Trading levels for SVRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.95 2.91 %
R2 4.88 1.36 %
R1 4.83 0.405 %
Current price: 4.81
Support S1 4.68 -2.69 %
S2 4.63 -3.64 %
S3 4.56 -5.19 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.16 7.28 %
R2 5.05 4.99 %
R1 5.00 3.95 %
Current price 4.81
Support S1 4.80 -0.208%
S2 4.79 -0.416%
S3 4.71 -2.08%

SVRA Predictions History

3 years ago
JS predicted that SVRA for 2021-04-13 is going $1.82 (1.11%)

3 years ago
JS predicted that SVRA for 2021-04-01 is going $2.05 (-8.89%)

3 years ago
JS predicted that SVRA for 2021-03-18 is going $2.21 (3.76%)

3 years ago
jjsheets330 predicted that SVRA for 2021-03-18 is going $5.50 (136.05%)

3 years ago
JS predicted that SVRA for 2021-03-03 is going $1.78 (3.49%)

3 years ago
JS predicted that SVRA for 2021-03-01 is going $1.72 (-5.49%)

3 years ago
JS predicted that SVRA for 2020-10-26 is going $1.18 (1.72%)

3 years ago
Woody predicted that SVRA for 2020-10-26 is going

Rank:

4 years ago
GoldenNugget predicted that SVRA for 2019-05-07 is going $11.06 (-0.54%)

4 years ago
Alex.TinyVillianaire.Goh.110165 predicted that SVRA for 2019-05-06 is going $10.74 (-3.50%)

Rank:
Click to get the best stock tips daily for free!

About Savara Inc

Savara Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.... SVRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT